申请人:Castelot-Deliencourt-Godefroy Géraldine
公开号:US20110034402A1
公开(公告)日:2011-02-10
This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, in particular for use thereof as a drug, notably in the treatment of diabetes.